Post by marykudro on Sept 22, 2022 7:35:19 GMT -5
Exemptia, generic name or API Adalimumab, is a potent TNF-inhibitor and anti-inflammatory medicinal product manufactured and promoted by Zydus in India. The drug exemptia injection is designed to act as anti-TNF, halting the overproduction of TNF and its hazardous effects on the body. This medicinal product is prescribed to those who have Rheumatoid Arthritis (RA), Psoriatic Arthritis, Ankylosing Spondylitis and to children having Juvenile Idiopathic Arthritis. The proposed dosage for Rheumatoid Arthritis is 40 mg once every two weeks. Please contact Ikris Pharma Network via, WhatsApp: +91 8130290915, Or Email: info@ikrispharmanetwork.com, Or simply filling the query form in our website. Exemptia can be made available on the basis of Named Patient Program (NPP).